Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Factor IX (FIX) Contained in AlphaNine® and Its Pharmacokinetic Comparison With BeneFIX® in Patients With Severe Hereditary Haemophilia B

NCT03091751 is registered in ClinicalTrials.gov with Grifols Biologicals, LLC as lead sponsor.

NCT NCT03091751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03091751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Factor IX (FIX) Contained in AlphaNine® and Its Pharmacokinetic Comparison With BeneFIX® in Patients With Severe Hereditary Haemophilia B
Lead sponsor
Grifols Biologicals, LLC
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
October 31, 2009
Enrollment
13 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b